AI CuratorAI-generated
Research summary · AI summary · not yet reviewedHuman studyNot reportedTrial registry
Real-World DMT Use Patterns in Pregnant Women with MS
The study aims to investigate the real-world use of disease modifying therapies (DMTs) before, during, and after pregnancy among 2,607 women diagnosed with multiple sclerosis who have given birth recently.
- Tags
- #MSResearch
- Most relevant to
- —
- Source
- Read original source
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
Why it matters
Understanding DMT use in this context is critical since pregnancy can significantly impact disease management for women with MS. Recognizing these patterns may inform future healthcare practices.
What this does not prove
The study has not yet posted results, and the planned enrollment and endpoints do not qualify as findings.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Not reported
- Participants / samples
- 2607 · basis not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- Not reported
- Evidence reviewed
- Trial registry record
- Regulatory approval
- Not reported
- Research areas
- Not classified
Original sources
Supporting passages (5)
subjectsWomen with a confirmed diagnosis of MS who had a live birth any time from August 20, 2020 to September 30, 2024 (identification period) or 6 months prior to end of study period.
sample size"count": 2607, "type": "ESTIMATED"
primary endpoint"measure": "Proportion of Patients With ≥1 DMT Claim During the Pre-Conception Period",
findingsThis study aims to assess the real-world patterns of disease modifying therapy (DMT) use before, during, and after pregnancy in women with multiple sclerosis (MS).
limitationsNo results are posted. Planned enrolment and endpoints are not findings.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.